Поисковый запрос: (<.>S=ФАРМАКОГЕНОМИКА<.>) |
Общее количество найденных документов : 71
Показаны документы с 1 по 20
|
|
1.
| Abacavir hypersensitivity reaction: An update // Ann. Pharmacother., 2008. Vol. 42, N 3.-С.387-396
|
2.
| Abacavir hypersensitivity reaction: An update // Ann. Pharmacother., 2008. Vol. 42, N 3.-С.387-396
|
3.
| Addresing the challenges of the clinical application of pharmacogenetic testing // Clin. Pharmacol. and Ther., 2009. Vol. 86, N 1.-С.28-31
|
4.
| Apports de la pharmacogenomique et de la pharmacogenetique dans les cancers digestifs // Oncologie, 2005. Vol. 7, N 8.-С.619-625
|
5.
| Apports de la pharmacogenomique et de la pharmacogenetique dans les cancers digestifs // Oncologie, 2005. Vol. 7, N 8.-С.619-625
|
6.
| Fuhr U. Appropriate phenotyping procedures for drug metabolizing enzymes and transporters in humans and their simultaneous use in the "Cocktail" approach // Clin. Pharmacol. and Ther., 2007. Vol. 81, N 2.-С.270-283
|
7.
| Fuhr U. Appropriate phenotyping procedures for drug metabolizing enzymes and transporters in humans and their simultaneous use in the "Cocktail" approach // Clin. Pharmacol. and Ther., 2007. Vol. 81, N 2.-С.270-283
|
8.
| Association of the HTR2C gene and antipsychotic induced weight gain: A meta-analysis // Int. J. Neuropsychopharmacol., 2007. Vol. 10, N 5.-С.697-704
|
9.
| Association study of the INPP1, 5HTT, BDNF, AP-2'бета' and GSK-3'бета' GENE variants and restrospectively scored response to lithium prophylaxis in bipolar disorder // Neurosci. Lett., 2006. Vol. 403, N 3.-С.288-293
|
10.
| McLeod Howard L. Cancer pharmacogenomics: SNPs, chips, and the individual patient // Cancer Invest., 2003. Vol. 21, N 4.-С.630-640
|
11.
| McLeod Howard L. Cancer pharmacogenomics: SNPs, chips, and the individual patient // Cancer Invest., 2003. Vol. 21, N 4.-С.630-640
|
12.
| Phillips Kathryn A. Cost-effectiveness issues in pharmacogenomics // Drug Metab. Rev., 2002. Vol. 35, прил. 1.-С.20
|
13.
| CYP2C19 genotype status and effect of omeprazole on intragastric pH in humans // Clin. Pharmacol. and Ther., 1999. Vol. 65, N 5.-С.552-561
|
14.
| Lee C.R. CYP2C9 genotype as a predictor of drug disposition in humans // Meth. and Find. Exp. and Clin. Pharmacol., 2004. Vol. 26, N 6.-С.463-472
|
15.
| Drug development in oncology: Classical cytotoxics and molecularly targeted agents // Brit. J. Clin. Pharmacol., 2006. Vol. 61, N 1.-С.15-26
|
16.
| Drug development in oncology: Classical cytotoxics and molecularly targeted agents // Brit. J. Clin. Pharmacol., 2006. Vol. 61, N 1.-С.15-26
|
17.
| Nguyen A. Enhancing race-based prescribing precision with phamacogenomics // Clin. Pharmacol. and Ther., 2007. Vol. 81, N 3.-С.323-325
|
18.
| Nguyen A. Enhancing race-based prescribing precision with phamacogenomics // Clin. Pharmacol. and Ther., 2007. Vol. 81, N 3.-С.323-325
|
19.
| Evidence for oxazepam as an in vivo probe of UGT2B15: Oxazepam clearance is reduced by UGT2B15 D85Y polymorphism but unaffected by UGT2B17 deletion // Brit. J. Clin. Pharmacol., 2009. Vol. 68, N 5.-С.721-730, 797
|
20.
| Evidence for oxazepam as an in vivo probe of UGT2B15: Oxazepam clearance is reduced by UGT2B15 D85Y polymorphism but unaffected by UGT2B17 deletion // Brit. J. Clin. Pharmacol., 2009. Vol. 68, N 5.-С.721-730, 797
|
|
|
|
Главная
Назад
"Электронные каталоги и базы данных библиотек СО РАН"